Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome
Clinical trial NCT07135050 · RECRUITING
Trial details
- NCT number
- NCT07135050
- Sponsor
- Mahzi Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-19
- Primary completion
- 2029-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.